ANG Lifesciences India Ltd manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vialsBusiness Overview: Company manufactures and sells products like injections, tablets, capsules, syrups, ointments of different varieties. It deals in 4 market segments: institutional segment, third party manufacturing, direct marketing and export...
ANG Lifesciences India has provided a compliance confirmation from its share transfer agent. This update assures investors that all physical shares submitted for dematerialization have been processed correctly. The company confirms that these securities were duly listed on the exchange, physical certificates were cancelled after verification, and the electronic ownership...
ANG Lifesciences India Limited has announced a board meeting on 20.06.2025 to consider the financial results for the quarter and half-year. The company published audited standalone and consolidated financial results showing a standalone net profit after tax of Rs. 112.74 lakh for the year, improving from a loss of Rs....
ANG Lifesciences India Limited has submitted its Annual Secretarial Compliance Report, confirming adherence to applicable statutory provisions and corporate governance practices for the financial year ended March 31, 2025. The company maintained proper board processes, timely updated required policies, preserved documents as per regulations, and ensured accurate disclosures on its...
